We are live on ! Find out more
TGHSA

TPG Group Holdings (SBS) Advisors Portfolio holdings

AUM $10.1B
1-Year Est. Return 22.58%
This Fund
S&P 500
This Quarter Est. Return
-6.74%
1 Year Est. Return
+22.58%
3 Year Est. Return
+44.33%
5 Year Est. Return
+103.05%
10 Year Est. Return
AUM
$6.79B
AUM Growth
+$146M
Cap. Flow
+$933M
Cap. Flow %
13.74%
Top 10 Hldgs %
69.7%
Holding
58
New
7
Increased
16
Reduced
7
Closed
7

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$407M
2
WP
Worldpay, Inc.
WP
+$181M
3
SPOT icon
Spotify
SPOT
+$124M
4
MGY icon
Magnolia Oil & Gas
MGY
+$100M
5
AVGO icon
Broadcom
AVGO
+$90M

Sector Composition

Rank Sector Weight
1 Healthcare 28.58%
2 Technology 25.31%
3 Real Estate 16.21%
4 Financials 9.56%
5 Communication Services 6.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLX icon
26
Sixth Street Specialty
TSLX
$1.63B
$57M 0.84%
2,717,043
CTSH icon
27
Cognizant
CTSH
$24.9B
$56.9M 0.84%
943,977
+231,955
+33% +$14.7M
ET icon
28
Energy Transfer Partners
ET
$70.1B
$53.1M 0.78%
4,057,738
+349,688
+9% +$4.88M
LBTYK icon
29
Liberty Global Class C
LBTYK
$3.53B
$49.3M 0.73%
+2,070,735
New +$53.9M
AMRX icon
30
Amneal Pharmaceuticals
AMRX
$5.85B
$47M 0.69%
16,213,367
+12,328,767
+317% +$43M
SONY icon
31
Sony
SONY
$137B
$44.2M 0.65%
3,733,740
+659,490
+21% +$7.45M
ATEX icon
32
Anterix
ATEX
$1.81B
$35.3M 0.52%
974,354
-38,556
-4% -$1.63M
LBTYA icon
33
Liberty Global Class A
LBTYA
$3.62B
$31.8M 0.47%
+1,286,835
New +$34.3M
TRVI icon
34
Trevi Therapeutics
TRVI
$2.59B
$28.5M 0.42%
6,324,319
STSA
35
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$28.3M 0.42%
+1,885,939
New +$29.3M
ALDR
36
DELISTED
Alder Biopharmaceuticals
ALDR
$23.4M 0.34%
1,238,533
COLL icon
37
Collegium Pharmaceutical
COLL
$1.15B
$16.5M 0.24%
1,436,960
BYND icon
38
Beyond Meat
BYND
$292M
$16.5M 0.24%
110,705
+23,389
+27% +$3.85M
TNDM icon
39
Tandem Diabetes Care
TNDM
$1.34B
$14.7M 0.22%
249,620
ALBO
40
DELISTED
Albireo Pharma Inc
ALBO
$14.3M 0.21%
716,381
FLXN
41
DELISTED
Flexion Therapeutics, Inc.
FLXN
$12.8M 0.19%
936,507
DOMO icon
42
Domo
DOMO
$174M
$12.1M 0.18%
754,056
PCG icon
43
PG&E
PCG
$38.3B
$10M 0.15%
1,000,000
GSKY
44
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$8.61M 0.13%
1,257,977
GCVRZ
45
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$7.42M 0.11%
13,240,462
ETTX
46
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$6.08M 0.09%
1,020,748
OTIC
47
DELISTED
Otonomy, Inc.
OTIC
$5.16M 0.08%
2,159,335
RAD
48
DELISTED
Rite Aid Corporation
RAD
$3.68M 0.05%
529,786
FPH icon
49
Five Point Holdings
FPH
$376M
$3.48M 0.05%
464,676
XIN
50
DELISTED
Xinyuan Real Estate
XIN
$3.4M 0.05%
83,699
-49,060
-37% -$2.05M

Similar funds

TPG Group Holdings (SBS) Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, TPG Group Holdings (SBS) Advisors held 58 positions worth $6.79B, up 2.2% from $6.64B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

TPG Group Holdings (SBS) Advisors deployed $933M of net new capital in Q3 2019, opening 7 new positions and adding to 16 existing holdings. Its largest new stake was Cushman & Wakefield Ltd: 52,030,940 shares worth $964M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 36% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was IQVIA, an estimated $407M trimmed.

  • TPG Group Holdings (SBS) Advisors's largest Q3 2019 buy was Cushman & Wakefield Ltd: 52,030,940 shares worth $964M.
  • TPG Group Holdings (SBS) Advisors added most to Elevance Health in Q3 2019, an estimated $60.3M increase.
  • TPG Group Holdings (SBS) Advisors's biggest Q3 2019 reduction was IQVIA, cutting an estimated $407M.
  • TPG Group Holdings (SBS) Advisors fully exited Worldpay, Inc. in Q3 2019, selling an estimated $181M.
  • TPG Group Holdings (SBS) Advisors's ten largest holdings make up 70% of its $6.79B portfolio in Q3 2019.
  • TPG Group Holdings (SBS) Advisors opened 7 new positions and closed 7 in Q3 2019.
  • TPG Group Holdings (SBS) Advisors's portfolio value rose 2.2% quarter-over-quarter to $6.79B.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.